Legal Representation
Attorney
Michelle E. Tochtrop
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 7, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 7, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 7, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 7, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 7, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Mar 29, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Mar 6, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Mar 6, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Jan 1, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Oct 1, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Oct 1, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Sep 14, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Aug 28, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Aug 28, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Jul 16, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 16, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 16, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 16, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 26, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 10, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 10, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 10, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 10, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 2, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Dec 7, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Dec 7, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Dec 7, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Dec 6, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 7, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Apr 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Mar 31, 2023 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 001
Micro-organisms and cultures of micro-organisms, in particular bacteria for use in food manufacture, bifidobacterium probiotic bacteria for use in the manufacture of food supplements, food, cosmetics, yeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings and reared animal species, not for medical or veterinary use for use in the manufacture of food supplements, food, cosmetics; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form, namely, probiotic bacteria for use in the manufacture of food supplements, food, cosmetics
Class 005
Micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; specialty pharmaceuticals containing micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, in the form of pharmaceuticals for oral application, in particular capsules, compress, solutions, suspensions, granules, granulates in dried or freeze-dried form, food supplements, food supplements for medical use containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings, not for medical use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria and prebiotic fibres
Classification
International Classes
001
005